Akela Pharma, Inc.

Quick facts

Phase 3 pipeline

• Fentanyl TAIFUN · Pain Management
  Fentanyl TAIFUN is a transdermal or inhalation formulation of fentanyl, a potent synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Akela Pharma, Inc. portfolio CI brief
• Akela Pharma, Inc. pipeline updates RSS